Decentralized Trials Are Here To Stay; What Challenges Do They Face?
Decentralized trials took a leap in popularity over the past few years, in part thanks to the COVID-19 pandemic. In Vivo's sister publication Medtech Insight spoke to two executives at clinical research technology companies about running decentralized clinical trials to discuss the benefits and limitations of trials run remotely.
You may also be interested in...
The companies will connect Biotronik’s implantable cardiac monitors with AliveCor’s personal electrocardiogram system to give physicians a more complete picture of their patients’ cardiac data.
There is potential for ethnic and socio-economic bias in medical device design, funding allocation and regulatory guidelines, according to the UK’s Department of Health and Social Care (DHSC), which has commissioned a review to uncover the extent of the problem.
The company is developing combination products that link software and therapeutics to personalize drug and care regimens.